We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma (VCR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00980395
Recruitment Status : Active, not recruiting
First Posted : September 21, 2009
Last Update Posted : December 5, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Arizona

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : September 12, 2014
  Estimated Study Completion Date : December 31, 2021